Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of AChE Inhibitors on Brain Chemicals in Alzheimer's Disease
NCT00104442Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2003
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of rivastigmine in Alzheimer's disease (AD), sponsored by Novartis. Started Oct 2003; status: completed.
02
Drugs
rivastigmine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00104442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104442.